Exempt Review Process

Exempt Review Process

Although the category is called Exempt Review, this type of research does require IRB review and registration. There are no deadlines for IRB applications categorized as Exempt Review. Research Integrity and Compliance (RIC) or the IRB chairperson conducts Exempt Reviews to ensure the study meets the ethical standards of Texas State University using the following criteria:

  1. The research involves no more than minimal risk to subjects.
  2. If subjects will be enrolled, selection is equitable.
  3. If there are interactions with subjects, there will be a consent process that will disclose such information as
    • Activity involving research
    • The purpose of the research
    • A description of the procedures
    • The amount of time required for the research
    • How data is maintained and secured
    • Risks of participating in the study
    • Benefits of participating in the study
    • Participation is voluntary
    • Name and contact information for the Investigator
    • Contact information for the Texas State IRB
    • Adequate provisions to maintain the privacy interests of subjects
  4. If the IRB Reviewer requires additional information or modifications, the IRB Reviewer will contact the PI via our electronic submission system Kuali. The IRB Reviewer will review the PI’s response upon receipt. If the PI does not respond within 30 days, the study will be abandoned.
  5. When the initial application or requested revisions are insufficient, RIC may request additional revisions.
  6. Once the review and/or revision process is complete, a letter will be sent to the researcher notifying him/her of the result of the Exempt Review. The letter will include the specific category of review.
  7. If it is determined that the study does not qualify for Exempt Review, the study will be referred for Expedited or Full Board Review as applicable.
  8. Exempt Review studies do not expire; therefore, Renewals are not required.
  1. If a researcher wants to make a change to an Exempt study, the researcher must submit an Amendment to the IRB. RIC will review the proposed change to ensure that the activities in the study do not change the level of review.
  2. If the requested change does not fall within an Exempt category and the study is verified by RIC to be human subject research, the study will need to undergo an Expedited or Full Board Review prior to implementation.
  3. If the researcher has concerns about the IRB’s decision or recommendations, the researcher may address his/her concerns to the IRB in writing. This request should include a justification for changing the IRB’s decision. The researcher should send this request to RIC.
     

Exempt Review Categories

To qualify for review at the exempt level, the research must not be greater than minimal risk and must fall into one or more of the exempt categories described below.

  • Research, conducted in established or commonly accepted educational settings, that specifically involves normal educational practices that are not likely to adversely impact students’ opportunity to learn required educational content or the assessment of educators who provide instruction. This includes most research on regular and special education instructional strategies, and research on the effectiveness of or the comparison among instructional techniques, curricula, or classroom management methods.

     

    Examples:

    • Effectiveness of on-line training as supplement to regular instructional approach
    • Evaluation of two currently implemented instructional techniques, curricula, or classroom management methods
  • Research that only includes interactions involving educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures, or observation of public behavior (including visual or auditory recording) if at least one of the following criteria is met :

    • information obtained is recorded in such a manner that human subjects can be identified, directly or through identifiers linked to the subjects; and
    • Any disclosure of the human subjects’ responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, educational advancement, or reputation; or
    • The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained, directly or through identifiers linked to the subjects, and an IRB conducts a limited IRB review to make the determination required by §46.111(a)(7).

    Examples:

    • Focus group of adult community members to discuss access to dental care.
    • An observational study of pedestrians crossing a street, that consists of the researcher taking notes of what occurs, recording sex, race, and type of clothing of pedestrians, but does not interact with subjects.
  • Research involving benign behavioral interventions in conjunction with the collection of information from an adult subject through verbal or written responses (including data entry) or audiovisual recording if the subject prospectively agrees to the intervention and information collection and at least one of the following criteria is met:

    • The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained, directly or through identifiers linked to the subjects;
      • Any disclosure of the human subjects’ responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, educational advancement, or reputation; or
      • The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained, directly or through identifiers linked to the subjects, and an IRB conducts a limited IRB review to make the determination required by §46.111(a)(7)
    • For the purpose of this provision, benign behavioral interventions are brief in duration, harmless, painless, not physically invasive, not likely to have a significant adverse lasting impact on the subjects, and the investigator has no reason to think the subjects will find the interventions offensive or embarrassing., having them solve puzzles under various noise conditions, or having them decide how to allocate a nominal amount of received cash between themselves and someone else.
    • If the research involves deceiving the subjects regarding the nature or purposes of the research, this exemption is not applicable unless the subject authorizes the deception through a prospective agreement to participate in research in circumstances in which the subject is informed that he or she will be unaware of or misled regarding the nature or purposes of the research.

    Examples:

    • Study among young adults evaluating preferred snack foods following a television program.
    • Asking subjects to play an online game that takes 30 minutes to complete.
    • Having subject solve puzzles under various noise conditions
  • Secondary research for which consent is not required: Secondary research uses of identifiable private information or identifiable biospecimens, if at least one of the following criteria is met:

    • The identifiable private information or identifiable biospecimens are publicly available;
    • Information, which may include information about biospecimens, is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained directly or through identifiers linked to the subjects, the investigator does not contact the subjects, and the investigator will not re-identify subjects;
    • The research involves only information collection and analysis involving the investigator’s use of identifiable health information when that use is regulated under 45 CFR parts 160 and 164, subparts A and E, for the purposes of "health care operations" or "research" as those terms are defined at 45 CFR 164.501 or for "public health activities and purposes" as described under 45 CFR 164.512(b); or
    • The research is conducted by, or on behalf of, a Federal department or agency using government-generated or government-collected information obtained for non-research activities, if the research generates identifiable private information that is or will be maintained on information technology that is subject to and in compliance with section 208(b) of the E-Government Act of 2002, 44 U.S.C. 3501 note, if all of the identifiable private information collected, used, or generated as part of the activity will be maintained in systems of records subject to the Privacy Act of 1974, 5 U.S.C. 552a, and, if applicable, the information used in the research was collected subject to the Paperwork Reduction Act of 1995, 44 U.S.C. 3501 et seq.

    Examples:

    • A study involving secondary research of audio archives in a public library.
    • Patient data extracted from medical records without name or ID number every 6 months as follow up visits occur.
    • An analysis of biospecimens from an IRB-approved biorepository.
  • Research and demonstration projects that are conducted or supported by a Federal department or agency, or otherwise subject to the approval of department or agency heads (or the approval of the heads of bureaus or other subordinate agencies that have been delegated authority to conduct the research and demonstration projects), and that are designed to study, evaluate, improve, or otherwise examine public benefit or service programs, including procedures for obtaining benefits or services under those programs, possible changes in or alternatives to those programs or procedures, or possible changes in methods or levels of payment for benefits or services under those programs. Such projects include, but are not limited to, internal studies by Federal employees, and studies under contracts or consulting arrangements, cooperative agreements, or grants. Exempt projects also include waivers of otherwise mandatory requirements using authorities such as sections 1115 and 1115A of the Social Security Act, as amended.

    • Each Federal department or agency conducting or supporting the research and demonstration projects must establish, on a publicly accessible Federal Web site or in such other manner as the department or agency head may determine, a list of the research and demonstration projects that the Federal department or agency conducts or supports under this provision. The research or demonstration project must be published on this list prior to commencing the research involving human subjects.

    Examples:

    • Outcomes assessment from government-sponsored mental health services
    • Study of barriers to obtaining new Medicare benefits
  • Taste and food quality evaluation and consumer acceptance studies:

    • If wholesome foods without additives are consumed, or
    • If a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural chemical or environmental contaminant at or below the level found to be safe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the U.S. Department of Agriculture.

    Examples:

    • A taste-test on different varieties of a fruit to determine consumer preference, when the fruits do not have any additives and subjects are asked to indicate which fruit they prefer.
    • Study looking at approved levels of an agricultural chemical on taste of vegetables.
    • A study that involves taste-testing of various beef products from cattle that have been given feed with a chemical additive. If the researcher can document that the amount of the additive was at or below the levels approved by the USDA, the research may qualify for it.
  • Storage or maintenance for secondary research for which broad consent is required: Storage or maintenance of identifiable private information or identifiable biospecimens for potential secondary research use if an IRB conducts a limited IRB review and makes the determinations required by §46.111(a)(8).
    Examples:

    • Creating a dataset containing identifiers from a previous study to conduct future research.
    • Saving blood samples from collaborator’s study for a future research question
  • Secondary research for which broad consent is required: Research involving the use of identifiable private information or identifiable biospecimens for secondary research use, if the following criteria are met:

    1. Broad consent for the storage, maintenance, and secondary research use of the identifiable private information or identifiable biospecimens was obtained in accordance with §46.116(a)(1) through (4), (a)(6), and (d);
    2. Documentation of informed consent or waiver of documentation of consent was obtained in accordance with §46.117;
    3. An IRB conducts a limited IRB review and makes the determination required by §46.111(a)(7) and makes the determination that the research to be conducted is within the scope of the broad consent referenced in paragraph (d)(8)(i) of this section; and
    4. The investigator does not include returning individual research results to subjects as part of the study plan. This provision does not prevent an investigator from abiding by any legal requirements to return individual research results.

    Examples:

    • Using dataset from prior study containing identifiers to answer subsequent research question.
    • Using blood samples from collaborator’s study for an additional research question.

Research not Eligible for Exempt Review

Human subject research that does not apply to one of the Exempt Review categories will undergo an Expedited or Full Board Review Process.

Research is not eligible for an Exempt Review if it:

  • is greater than minimal risk
  • uses vulnerable populations as research subjects. Minors (less than 18 years of age) are allowed only under category 1 if applicable
  • involves collection of identifiable information from subjects if recorded in an identifiable manner and sensitive (not low risk if disclosed)
  • involves administration or use of drugs or medical devices
  • involves non authorized deception 
  • involves the audio or video recording of adult research participants in a non- anonymous manner and disclosure is sensitive (not low risk); recording of minors if not part of normal educational practice
  • involves exercise
  • Collection of blood samples or biological specimens